PharmexecMike

Editor at MJH Life Sciences for Pharmaceutical Exec

[Pharmaceutical Executive @PharmExec]

🔸Read about 2023 #EmergingPharmaLeader Justin To, Chief Operating Officer, Skeletal Dysplasias and Gene Therapy, @BridgeBioPharma ! 🔸
The recipe for cross-functional collaboration in #drugdevelopment🖋️Mike Hollan
➡️https://t.co/gyd2mJCsUX

#GeneTherapy #pharmaceutical

[Pharmaceutical Executive @PharmExec]

🔸Congratulations to our 2023 Emerging Pharma Leaders🔸
Natasha Hernday of @SeagenGlobal
Simon Holland of @organonbiosim
Justin To of @BridgeBioPharma
Frank Watanabe of @ArcutisBio
Hanadie Yousef of Juvena Therapeutics

Read their profiles here: https://t.co/RmoqIBSn9Y

[Pharmaceutical Executive @PharmExec]

🚨Our July issue is LIVE🚨
An insightful discussion with @OtsukaUS' Christine Sakdalan🔷the changing role of #biopharma CFOs🔷Rethinking commission-based deals with independent contractors🔷and so much more waiting right here➡️https://t.co/qi7AID1ikp

#pharma #lifesciences

[Pharmaceutical Commerce @PharmaCommerce]

🚨Our June issue is LIVE🚨
The impact of war on drug #supplychain ▪️What makes #hub programs successful?▪️Counting down to 2023 #DSCSA #compliance ▪️and so much more right here➡️https://t.co/T59ic1e9ZN

#pharma #lifesciences #pharmaceutical #manufacturing

[Pharmaceutical Commerce @PharmaCommerce]

🚨New Podcast Alert🚨
David Sanders, VP of government affairs & policy, @Coherus_Bio , speaks about the firm’s goal of expanding #patientaccess to cost-effective medication, his role with @samscoalition, and much more!
🎙️https://t.co/czEiwEmXKQ

#pharma #lifesciences #supplychain

[Pharmaceutical Executive @PharmExec]

🚨New Podcast Alert🚨
In episode 108, the rest of the PharmExec editorial staff join @PharmExecElaine Quilici and @mschmalfuhs to give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders
🎙️https://t.co/W2GCD8NoKp

#pharma